News from accelrys, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 22, 2003, 00:00 ET

Accelrys Announces Agreement to Distribute Jubilant Biosys' Kinase Inhibitor Database

SAN DIEGO, Dec. 22 /PRNewswire/ -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced a strategic...

Oct 15, 2003, 01:00 ET

Accelrys Announces the Release of Combimat 2.0

SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced the...

Oct 13, 2003, 01:00 ET

Accelrys to Deliver Key Life Sciences Software on Linux Platform

SAN DIEGO, Oct. 13 /PRNewswire-FirstCall/ -- Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced plans...

Sep 23, 2003, 01:00 ET

Accelrys Announces Strategic Distribution Agreement

SAN DIEGO, Sept. 23 /PRNewswire-FirstCall/ -- Accelrys, Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP) and active member of...

Sep 16, 2003, 01:00 ET

Accelrys and GEMA Demonstrate Successful Use of Discovery Studio Proteomics Solutions to Understand Cardiovascular Disease

SAN DIEGO, Sept. 16 /PRNewswire-FirstCall/ -- Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced...

Sep 08, 2003, 01:00 ET

Accelrys Announces Accord Enterprise Informatics 5.3 and DS Accord for Excel Enterprise

SAN DIEGO, Sept. 8 /PRNewswire-FirstCall/ -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced the...

Sep 08, 2003, 01:00 ET

Accelrys Announces DS Modeling 1.2 - SBD: Structure-Based Design Tools for Drug Discovery

SAN DIEGO, Sept. 8 /PRNewswire-FirstCall/ -- Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced the...

Sep 08, 2003, 01:00 ET

Accelrys Announces MS Modeling 3.0

SAN DIEGO, Sept. 8 /PRNewswire-FirstCall/ -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced the...

Jul 30, 2003, 01:00 ET

Accelrys Announces DS Modeling 1.1: First Discovery Studio(TM) X-Ray Tools for Target Characterization

SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced its...

Jul 17, 2003, 01:00 ET

Accelrys Announces DS Accord for Excel

SAN DIEGO, July 17 /PRNewswire-FirstCall/ -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced the...

Jul 15, 2003, 01:00 ET

Accelrys and Formation Systems Announce Strategic Distribution Agreement

SAN DIEGO and SOUTHBOROUGH, Mass., July 15 /PRNewswire-FirstCall/ -- Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq:...

Jul 01, 2003, 01:00 ET

Accelrys Announces The Release Of Catalyst 4.8

SAN DIEGO, July 1 /PRNewswire-FirstCall/ -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (NASDAQ: PCOP), today announced the...

Mar 25, 2003, 00:00 ET

Materials Studio(R) Software Moves Into Informatics

SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced the...

Mar 24, 2003, 00:00 ET

Accelrys and Wiley to Deliver New Structure-Searchable Chemical Reaction References

SAN DIEGO, March 24 /PRNewswire-FirstCall/ -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), and John Wiley and Sons,...

Feb 24, 2003, 00:00 ET

First AccelrysWorld Conference Opens in San Diego

SAN DIEGO, Feb. 24 /PRNewswire-FirstCall/ -- AccelrysWorld 2003, a new international conference focusing on the application of software and...

Feb 11, 2003, 00:00 ET

Accelrys To Provide Technology For Functional Annotation of Confirmant's Protein Atlas of the Human Genome(TM)

SAN DIEGO and ABINGDON, England, Feb. 11 /PRNewswire-FirstCall/ -- Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq:...

Feb 03, 2003, 00:00 ET
A F ACCELRYS DR. SCOTT KAHN ACCELRYS DR. SCOTT KAHN

Dr. Scott Kahn, chief science officer. Dr. Kahn has guided the commercial development of some of the world's most widely-used simulation products. He is a strategist and frequent conference speaker on topics relating to the use of information technology to enhance productivity in the discovery of new therapeutics. His record includes involvement in the SPARTAN program, in developing analysis tools for medicinal chemistry research, and in the creation of a number of widely-used commercial modeling packages. (PRNewsFoto)[TC]
 SAN DIEGO, CA USA
 02/03/2003

Accelrys Appoints Chief Science Officer

SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced the...

Jan 20, 2003, 00:00 ET

Cerius2 Available with Three New Scientific Modules

SAN DIEGO, Jan. 20 /PRNewswire-FirstCall/ -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced the...

Nov 20, 2002, 00:00 ET

Accelrys to Host AccelrysWorld 2003 in San Diego

SAN DIEGO, Nov. 20 /PRNewswire-FirstCall/ -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), announced today that it...

Nov 11, 2002, 00:00 ET

Accelrys Announces Three-Year Licensing Agreement With Intervet

SAN DIEGO, Nov. 11 /PRNewswire-FirstCall/ -- Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), today announced a...